News
SAN DIEGO, June 20, 2025--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company today announced the Tandem t:slim X2™ insulin pump with Control ...
SAN DIEGO, June 20, 2025--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company today announced the Tandem t:slim X2™ insulin pump with Control-IQ+ ...
Zacks Investment Research on MSN1d
TNDM Stock Gains on t:slim X2's Compatibility With FreeStyle Libre 3Tandem Diabetes Care, Inc.’s TNDM t:slim X2 insulin pump with Control-IQ+ automated insulin delivery (AID) technology is now compatible with Abbott’s FreeStyle Libre 3 Plus continuous glucose ...
t:slim X2, meanwhile, is powered by Control-IQ+ technology. Tandem designed the advanced hybrid closed-loop automated insulin ...
Multiple developers of connected diabetes hardware have announced plans this week to link their insulin pumps with continuous ...
Medical Device Network on MSN1d
Tandem’s t:slim X2 pump now works with Abbott’s FreeStyle CGM sensorTandem Diabetes Care has announced its Tandem t:slim X2 insulin pump is now compatible with Abbott’s FreeStyle Libre 3 Plus ...
The latest version of Abbott's FreeStyle Libre continuous glucose monitor is now available via the NHS to eligible people with diabetes in the UK. Abbott's wearable FreeStyle Libre 3 device ...
The pump is also part of the Control-IQ+ automated insulin delivery (AID) system.The t:slim X2 integrates with the Dexcom G6 and G7, and Abbott's FreeStyle Libre 2 Plus/3 Plus. Control-IQ+ is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback